TORCH study results: pharmacotherapy reduces lung function decline in patients with chronic obstructive pulmonary disease

Hosp Pract (1995). 2010 Apr;38(2):92-3. doi: 10.3810/hp.2010.04.299.
No abstract available

Publication types

  • Comment

MeSH terms

  • Administration, Inhalation
  • Aged
  • Albuterol / administration & dosage
  • Albuterol / analogs & derivatives*
  • Androstadienes / administration & dosage*
  • Body Mass Index
  • Bronchodilator Agents / administration & dosage*
  • Disease Progression
  • Double-Blind Method
  • Drug Therapy, Combination
  • Female
  • Fluticasone
  • Follow-Up Studies
  • Forced Expiratory Volume / drug effects
  • Humans
  • Male
  • Middle Aged
  • Pulmonary Disease, Chronic Obstructive / diagnosis
  • Pulmonary Disease, Chronic Obstructive / drug therapy
  • Pulmonary Disease, Chronic Obstructive / mortality
  • Risk Factors
  • Salmeterol Xinafoate
  • Smoking / adverse effects
  • Spirometry
  • Survival Analysis

Substances

  • Androstadienes
  • Bronchodilator Agents
  • Salmeterol Xinafoate
  • Fluticasone
  • Albuterol